Pages that link to "Q37351686"
Jump to navigation
Jump to search
The following pages link to Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database (Q37351686):
Displaying 28 items.
- Clinical profile of contraceptive progestins (Q28306370) (← links)
- Attitudes towards drugs--a survey in the general population (Q30838607) (← links)
- Pitfalls of pharmacoepidemiology (Q33803070) (← links)
- Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms (Q34086042) (← links)
- Hormonal contraception and thrombotic risk: a multidisciplinary approach. (Q34513007) (← links)
- Oral contraceptives and venous thromboembolism: which are the safest preparations available? (Q34743953) (← links)
- Tentative guidelines and practical suggestions to avoid venous thromboembolism during oral contraceptive therapy (Q34743964) (← links)
- Oral contraception and the risk of thromboembolism: what does it mean to clinicians and their patients? (Q34966977) (← links)
- Hormonal birth control and pregnancy: a comparative analysis of thromboembolic risk (Q35139270) (← links)
- Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation (Q35603426) (← links)
- Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis (Q37363738) (← links)
- Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case-control studies using the QResearch and the CPRD databases (Q37704438) (← links)
- Impact of safety-related regulatory action on clinical practice: a systematic review. (Q38000336) (← links)
- A pathway to improved prospective observational post-authorization safety studies (Q38031932) (← links)
- Practices of prescribing oral contraceptives in Poland (Q43596073) (← links)
- Oral contraceptives and venous thromboembolism: a five-year national case-control study (Q43945035) (← links)
- The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study (Q44346348) (← links)
- Changes in prescription patterns of oral contraceptives in a northern Italian province: relation with venous thromboembolism (Q44481714) (← links)
- Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin. (Q44726414) (← links)
- Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations (Q47653552) (← links)
- Has the Time Come to Stratify and Score SUDEP Risk to Inform People With Epilepsy of Their Changes in Safety? (Q53683193) (← links)
- Pitfalls of pharmacoepidemiology. (Q55253263) (← links)
- Use of Hormone Replacement in Females with Endocrine Disorders (Q56029673) (← links)
- Pitfalls of pharmacoepidemiology (Q73177385) (← links)
- Pharmacoepidemiology and drug safety (Q73839673) (← links)
- [Hormonal oral contraceptives, coagulation and thrombosis] (Q77616306) (← links)
- Epidemiology on trial--confessions of an expert witness (Q78298488) (← links)
- The cost-effectiveness of periodic safety update reports for biologicals in Europe (Q86524099) (← links)